Table 2 Treatment outcome according to treatment strategy
Initial endocrine therapy (N = 137) | Initial chemotherapy (N = 78) | Chemotherapy - endocrine therapy (N = 57) | |
|---|---|---|---|
Progression-free survival – mo | |||
Median | 12.6 | 7.0 | 18.2 |
(95% CI) | (9.0–16.2) | (3.8–10.2) | (14.3–22.1) |
Overall survival – mo | |||
Median | 57.3 | 45.5 | 85.2 |
(95% CI) | (45.6–69.0) | (34.9–56.1) | (56.5–113.9) |
Best response – no. (%) | |||
Complete response | 7 (5.1%) | 3 (3.8%) | 7 (12.3%) |
Partial response | 29 (21.2%) | 18 (23.1%) | 39 (68.4%) |
Stable disease | 51 (37.2%) | 24 (30.8%) | 9 (15.8%) |
Progressive disease | 50 (36.5%) | 33 (42.3%) | 2 (3.5%) |
Complete or partial response | |||
No. of patients (%) | 36 (26.3%) | 21 (26.9%) | 46 (80.7%) |
(95% CI) | (18.9–33.6) | (17.6–36.7) | (70.4–90.9) |